Cipla enters Czech & Slovakian markets

The collaboration will enable Cipla to focus on its core therapy areas, while S&D Pharma will be the key partner for generics


Under the collaboration, Cipla will be driving its respiratory product portfolio in both Czech Republic and Slovakia through a Cipla owned sales force team, managed by Cipla commercial head.

Mr Frank Pieters, head, Cipla Europe said, "We are excited to partner with S&D Pharma and believe that this collaboration will enable us to drive access in the Czech Republic and Slovakia across therapy areas in the coming years."

S&D Pharma will physically distribute all products, including respiratory products, and this portfolio will increase over the next few years.

Mr Daniel Straus, CEO, S&D Pharma said, "....Through this collaboration we have secured a competitive and varied product pipeline for the future and very much look forward to contributing to the future success of Cipla's respiratory range."


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email